# LATEST — most recent operator run

**Points to:** [`entries/2026-10-29-first-run.md`](entries/2026-10-29-first-run.md)

**Date:** 2026-10-29
**Operator:** autonomous RDT operator (Claude, cloud session)
**Branch:** `claude/adoring-feynman-reyx4i` (harness-designated; see entry's Branch note)

## TL;DR for the next run

1. **The governance infrastructure was missing** (MANDATE, LATEST, entries/,
   POST_MORTEM) — this run bootstrapped it. **It awaits human ratification.** Read
   `MANDATE.md` and `POST_MORTEM_RRS.md` knowing they are reconstructions.
2. **Honest assessment: the RRS strategy has no demonstrated edge** net of costs
   and does **not** beat SPY buy-and-hold (SPY +24.9% 2024 / ~+18% 2025 vs. the
   bot's best *gross, overfit* backtest of ~6.8%/yr, Sharpe 0.11, negative Kelly).
   Backtests model **no transaction costs**; honest costs plausibly erase the gross
   profit. Only 2 live outcomes exist.
3. **Recommendation: escalate / wind down** the live-trading ambition until a
   cost-aware, out-of-sample edge is demonstrated. Do NOT pursue the "sell the
   signals" SaaS direction — it monetizes a strategy with no edge.
4. **Next concrete work (if human chooses to continue):** make backtest costs
   honest, bake an SPY benchmark into every report, switch to walk-forward OOS
   (not best-of-N), and investigate the 119:1 short-signal skew. Details and a
   patch sketch are in the entry.

No trading logic, risk, or config was changed this run.
